1701 related articles for article (PubMed ID: 28827067)
21. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid.
Kabeerdoss J; Jayakanthan P; Pugazhendhi S; Ramakrishna BS
Indian J Med Res; 2015 Jul; 142(1):23-32. PubMed ID: 26261163
[TBL] [Abstract][Full Text] [Related]
22. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
[TBL] [Abstract][Full Text] [Related]
23. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora.
Swidsinski A; Loening-Baucke V; Vaneechoutte M; Doerffel Y
Inflamm Bowel Dis; 2008 Feb; 14(2):147-61. PubMed ID: 18050295
[TBL] [Abstract][Full Text] [Related]
24. Decreased levels of serum omentin-1 in patients with inflammatory bowel disease.
Yin J; Hou P; Wu Z; Nie Y
Med Sci Monit; 2015 Jan; 21():118-22. PubMed ID: 25576244
[TBL] [Abstract][Full Text] [Related]
25. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
[TBL] [Abstract][Full Text] [Related]
26. Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease.
Pastor Rojo O; López San Román A; Albéniz Arbizu E; de la Hera Martínez A; Ripoll Sevillano E; Albillos Martínez A
Inflamm Bowel Dis; 2007 Mar; 13(3):269-77. PubMed ID: 17206721
[TBL] [Abstract][Full Text] [Related]
27. GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD.
Dierckx T; Verstockt B; Vermeire S; van Weyenbergh J
J Crohns Colitis; 2019 Mar; 13(3):389-394. PubMed ID: 30312386
[TBL] [Abstract][Full Text] [Related]
28. Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease.
Caliskan Z; Gokturk HS; Caliskan M; Gullu H; Ciftci O; Ozgur GT; Guven A; Selcuk H
Microvasc Res; 2015 Jan; 97():25-30. PubMed ID: 25128749
[TBL] [Abstract][Full Text] [Related]
29. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
30. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
31. Specificities of the fecal microbiota in inflammatory bowel disease.
Sokol H; Seksik P; Rigottier-Gois L; Lay C; Lepage P; Podglajen I; Marteau P; Doré J
Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
[TBL] [Abstract][Full Text] [Related]
32. Altered uric acid metabolism in isolated colonic Crohn's disease but not ulcerative colitis.
Zhu F; Feng D; Zhang T; Gu L; Zhu W; Guo Z; Li Y; Lu N; Gong J; Li N
J Gastroenterol Hepatol; 2019 Jan; 34(1):154-161. PubMed ID: 29926959
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
34. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
35. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease.
Zhang P; Liu X; Guo A; Xiong J; Fu Y; Zou K
Dig Dis Sci; 2016 Sep; 61(9):2608-18. PubMed ID: 27056038
[TBL] [Abstract][Full Text] [Related]
36. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
37. Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.
Šimurina M; de Haan N; Vučković F; Kennedy NA; Štambuk J; Falck D; Trbojević-Akmačić I; Clerc F; Razdorov G; Khon A; Latiano A; D'Incà R; Danese S; Targan S; Landers C; Dubinsky M; ; McGovern DPB; Annese V; Wuhrer M; Lauc G
Gastroenterology; 2018 Apr; 154(5):1320-1333.e10. PubMed ID: 29309774
[TBL] [Abstract][Full Text] [Related]
38. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
39. Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease.
Abreu-Delgado Y; Isidro RA; Torres EA; González A; Cruz ML; Isidro AA; González-Keelan CI; Medero P; Appleyard CB
World J Gastroenterol; 2016 Apr; 22(13):3581-91. PubMed ID: 27053850
[TBL] [Abstract][Full Text] [Related]
40. Serum adipokines in inflammatory bowel disease.
Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]